Skip to content
41

exodermin

Skip it

A small market ($8K/yr) — this niche doesn't clear our bar today.

Market size 2Growth 14Conversion 56Competition 15Returns 100Price range 91Avg price 95Brand share 20Review moat 97Quality gap 45

Returns

Incredible0.0%

return rate — above 6% kills the launch gate

Review moat

Incredible59.13

avg incumbent reviews — the moat a new listing must climb

Avg price

Incredible€33.89

avg listing price — sweet spot $15–$100

Price range

Great€10.29–€98.84

cheapest to priciest tracked listing — scored on the share inside $15–$100

Conversion

Good4.7%

search→purchase rate — share of searches ending in a sale

Quality gap

Okay4.5★

avg incumbent rating — lower means beatable quality

Brand share

Bad92%

top-5 brand share — brand-locked demand

Competition

Bad82%

top-5 click share — a locked-up shelf

Growth

Bad-21.3%

90-day search growth — must beat 0% to launch

Market size

Bad€8K

€8K/yr · 5K searches

Competition

The top 5 products capture 82% of clicks — a locked-up shelf that new listings rarely crack.

Brands

5 falling

Sellers

21

Top-5 brand share

92%

Open market

0%

  • Aktivanad39%
  • Exoderil20%
  • MayProducts15%
  • Skoczylas12%
  • --8%
  • MEDICE Arzneimittel Pütter GmbH&6%
  • Open — no brand owns it (0%)

Product shelf

Each bubble is one product — market share against review moat; bubble size tracks estimated sales, color grades how beatable the incumbent looks.

0%10%€81220%€2K30%€2K40%€3K1101001K Reviews — right = deep review moat Market share (90d) ≈ est. sales
Beatable (≤4.3★) Contested Strong incumbent (>4.7★)

All 8 tracked products in this niche — three views at once, no toggling.

Demand & seasonality

Weekly Amazon search volume, last 104 weeks — -21.3% search growth over the last 90 days.
250150Spike '25Prime Day '25Black Friday '25Spike '26SepDecMarJunAugNovMarMay

Peak months: Jul · busiest ÷ quietest = 1.7×

Reviews

What buyers praise and complain about, mined from review topics.

What buyers complain about

Preis-Leistungs-Verhältnis100%

“Leider sehr teuer”